Abbott Vascular3200 Lakeside Drivesanta Clara Ca 95054 Pma Numberp110019 Supplement Numbers120 Date Received04 06 2022 Decision Date05 06 2022 Product Code Niq Advisory Committee Cardiovascular Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Abbott Vascular3200 Lakeside Drivesanta Clara Ca 95054 Pma Numberp110019 Supplement Numbers120 Date Received04 06 2022 Decision Date05 06 2022 Product Code Niq Advisory Committee Cardiovascular Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P110019S120 ABBOTT VASCULAR3200 Lakeside Drivesanta Clara, CA 95054 PMA NumberP110019 Supplement NumberS120 Date Received04/06/2022 Decision Date05/06/2022 Product Code NIQ  Advisory Committee Cardiovascular Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted? No	XIENCE Skypoint Everolimus Eluting Coronary Stent System	2022-05-06